Triamcinolone Acetonide Injection 40 mg 

Triamcinolone acetonide is a high-potency corticosteroid (steroid) used for its anti-inflammatory and immunosuppressive effects. The 40 mg/mL injectable suspension (often sold as Kenalog-40) is given either intramuscularly (IM) or intra‐articularly (into joints) or even epidurally or intralesionally under a doctor’s supervision. It acts by modulating the immune system – reducing white blood cell activity and inflammatory mediator release – thus relieving swelling, pain, and allergic reactions in tissues

Triamcinolone Acetonide Injection Suspension is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. Each milliliter (mL) of this sterile, single-dose vial formulation contains 40 mg of triamcinolone acetonide as the active ingredient, designed for intramuscular, intra-articular, intrabursal, or intralesional administration.

Uses

Triamcinolone injection is used when oral steroids are not suitable or for targeted therapy. Indications include:

• Allergic/Immunologic disorders: Severe asthma or COPD exacerbations, anaphylaxis (second-line), allergic rhinitis (rarely), systemic lupus flares, and other systemic allergies.
• Rheumatologic conditions: Joint inflammation (arthritis, bursitis, gout, tendinitis). Intra-articular injections of triamcinolone (often 10–40 mg/joint) relieve inflammation in rheumatoid arthritis, osteoarthritis flares, and acute gouty attacks. (Up to ~80 mg total can be given if multiple joints are involved.)
• Dermatologic disorders: Severe eczema/dermatitis, psoriasis, or keloid/hypertrophic scar injections (intralesional). Local injections flatten and soften raised scars.
• Ophthalmic conditions: Uveitis, allergic conjunctivitis or episcleritis (by ophthalmologist), where steroid injection around the eye can reduce inflammation.
• Endocrine: Addison disease (adrenal insufficiency) or congenital adrenal hyperplasia as an interim replacement therapy if needed.
• Gastrointestinal: Inflammatory bowel disease (e.g. severe ulcerative colitis or Crohn’s flares) when IV/oral steroids are not feasible.
• Neurologic: Multiple sclerosis exacerbations (as part of acute relapse treatment), or perineural/epidural steroid injections for radiculopathy (though epidural triamcinolone use is off-label).
• Other: Hematologic (leukemias), renal (nephrotic syndrome), and other inflammatory diseases where systemic steroid effect is required.

Each use is dictated by a physician; triamcinolone 40 mg is not a self-administered drug. It is generally given only under medical supervision due to its potency and need for sterile injection technique.

Dosage and Administration

Triamcinolone 40 mg/mL is a suspension that must be shaken well before use. The dosage depends on the condition, route, and patient response:

• Intramuscular (Systemic) Injection: A common practice is a single deep gluteal IM injection of 40–60 mg (i.e. 1–1.5 mL of Kenalog-40). This provides several weeks of anti-inflammatory effect. Based on patient response, doses are typically adjusted between 20–80 mg; many start at ~60 mg.
• Intra-articular (Joint) Injection: For large joints, 10–40 mg per injection is usual. Smaller joints (wrist, ankle) may get 5–10 mg. The dose is injected directly into the joint space using sterile technique. If multiple joints need injections, total triamcinolone up to ~80 mg (e.g. 40 mg in two joints) has been done safely.
• Tendon/Bursal injections: Lower doses (10–20 mg) are used for tendonitis or bursitis.
• Subcutaneous/Intralesional: Very small amounts (1–5 mg) may be injected into scar tissue or keloids in multiple sessions; these are usually given as proprietary formulations or small volume of the suspension.
• Frequency: Intra-articular steroid injections are often limited (e.g. no more often than every 3–4 months in a given joint) to avoid cartilage damage. Systemic (IM) injections might be repeated every 1–3 months if needed, but long-term chronic use is usually switched to oral steroids for flexibility.

Administration Note: Always use aseptic technique. For IM injections, use a long needle (1½″ or longer) into the gluteal muscle. For joints, aspiration of excess fluid may precede injection, and local anesthetic is often used first. Patients should remove tight clothing from the injection site and report any redness or severe pain afterward.

Side Effects

As a potent corticosteroid, triamcinolone can cause systemic steroid effects even from a single shot (especially if large dose). Common side effects include:

• Post-injection pain or swelling at the injection site (often mild). Rarely, a “steroid flare” can cause transient worsening of joint pain for 1–2 days.

• Local tissue atrophy or depigmentation: If the injection leaks into subcutaneous tissue, it can cause skin thinning or whitening at that site. Tendon rupture (especially Achilles) is a rare but known risk of steroid injection into or around tendons.

• Infection risk: Corticosteroids suppress immune response, so risk of new infection or exacerbating latent infection (tuberculosis, herpes, etc.). Practitioners screen for infection before injections.

• Systemic steroid effects: Even from IM/IA injection, systemic absorption can occur. These include weight gain, fluid retention, and elevated blood pressure; hyperglycemia (be cautious in diabetics); insomnia and mood changes (euphoria, mood swings, anxiety, depression); acne or skin thinning; increased appetite; hair thinning; and bruising or easy bruising.

• Endocrine effects: High-dose or repeated steroids can suppress the hypothalamic-pituitary-adrenal (HPA) axis, leading to adrenal insufficiency if steroids are abruptly stopped. Long-term suppression can shrink adrenal glands; therefore, tapering or regular dosing schedule is important.

• Ocular: Long-term or repeated steroid exposure can cause cataracts and glaucoma (increased eye pressure). Patients receiving multiple injections should have periodic eye exams.

• Bone: Chronic use (or many repeated injections) can contribute to osteoporosis or avascular necrosis of bone. This is less likely with occasional injections but should be considered, especially in osteoarthritis of weight-bearing joints.

• Allergic: True allergy to triamcinolone is rare but possible. Watch for rash, itching, swelling, or anaphylaxis immediately after injection.

• Others: Corticosteroids can cause GI irritation. Patients with peptic ulcer disease should be monitored (though a single injection is less risky than oral steroids). Steroids can also alter mood (steroid-induced psychosis is rare with pulses) and increase infection risk.

Patients should be warned to report severe symptoms like visual changes (blurred vision, halos), severe headache, difficulty breathing, chest pain, or neurological symptoms (weakness, seizures), which would require urgent medical attention. For example, blurred vision or eye pain could signal increased eye pressure. Because of systemic absorption, shared immunizing: live vaccines should be avoided for 2+ months after a large steroid injection due to reduced immune response.

Caution: Corticosteroid injections should not be given into infected sites or with uncontrolled infections in the body. Use in pregnancy or nursing is generally avoided unless benefit outweighs risk; steroids cross the placenta and into breast milk.